NCT00361803View on ClinicalTrials.gov

Topotecan Pharmacokinetic Characterization Study

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

September 12, 2006

Primary Completion Date

August 9, 2007

Study Completion Date

August 9, 2007

Conditions

Cancer

Interventions

DRUG

topotecan

topotecan

Trial Locations (1)

85259

GSK Investigational Site, Scottsdale

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00361803 - Topotecan Pharmacokinetic Characterization Study | Biotech Hunter | Biotech Hunter